ALC-0315

ALC-0315

CAT N°: 34337
Price:

From 365.00 310.25

ALC-0315 is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs).{62365} Administration of severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA in ALC-0315-containing LNPs induces the production of IgG that binds to the SARS-CoV-2 receptor-binding domain (RBD) in rhesus macaques, with a boost in antigen-specific IgG geometric mean titers (GMT) seven and 14 days after a second dose. Formulations containing ALC-0315 have been used in the development of LNPs for the delivery of mRNA-based vaccines.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 2-hexyl-decanoic acid, 1,1′-[[(4-hydroxybutyl)imino]di-6,1-hexanediyl] ester
  • Correlated keywords
    • ALC0315 SARSCoV2 SARSCoV ALC315 covid-19 severe acute respiratory syndrom coronavirus 2 COVID19 Pfizer BioNTech
  • Product Overview:
    ALC-0315 is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs).{62365} Administration of severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA in ALC-0315-containing LNPs induces the production of IgG that binds to the SARS-CoV-2 receptor-binding domain (RBD) in rhesus macaques, with a boost in antigen-specific IgG geometric mean titers (GMT) seven and 14 days after a second dose. Formulations containing ALC-0315 have been used in the development of LNPs for the delivery of mRNA-based vaccines.

We also advise you